Page 2 - Rajen Manicka News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rajen manicka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rajen Manicka Today - Breaking & Trending Today

Beyond label claims: Clinical trial findings paramount to meet consumers' knowledge needs – Immunity Broadcast panel

Beyond label claims: Clinical trial findings paramount to meet consumers’ knowledge needs – Immunity Broadcast panel
Clinical trial findings are becoming ever more important in today’s world as consumers are looking beyond label claims and are actively reading up on the health benefits and evidence of ingredients used in immunity products, according to an expert panel.
The panel discussed the topic “Immunity and Clinical Trials/ Emerging Research” during the first broadcast of the NutraIngredients Immunity Interactive Broadcast Series from APAC. (Listen on demand here)
Industry experts involved in the discussion included Dr Amanda Rao, founder and principal investigator at RDC Clinical, Dr Daisuke Fujiwara, deputy GM of the Health Science Department at major MNC Kirin, Dr Samuel JK Abraham, head of R&D at GN Corporation (Japan), Dr Rajen Manicka, CEO of ASX-listed biotech firm Holista Colltech, and Dr Priyali Shah, lead scientis ....

Samuel Jk Abraham , Holista Colltech , Daisuke Fujiwara , Gary Scattergood , Ankur Bhamu , Rajen Manicka , Nichi Glucan , Amanda Rao , Priyali Shah , Clinical Trials Emerging Research , Gn Corporation Japan , Gn Corporation , Health Science Department , Function Claims , Ll Asia Pacific , Sian Tastes , Healthy Living , Industry Growth , Unctional Foods And Drinks , Clinical Trials , சாமுவேல் ஜுக் , ராஜன் மாணிக்க , ஞ் நிறுவனம் , ஆரோக்கியம் அறிவியல் துறை , செயல்பாடு கூற்றுக்கள் ,

NutraIngredients Immunity Series: Join us live tomorrow for opening broadcast on clinical trials and emerging research

NutraIngredients' interactive and FREE broadcast series focusing on immunity begins tomorrow, with the first APAC edition on clinical trials and emerging research coming live from our Singapore regional HQ. ....

United States , Sarah Culverhouse , Samuel Jk Abraham , Rebecca Edwards , Holista Colltech , Bevan Hayes , Gary Scattergood , Daisuke Fujiwara , Ankur Bhamu , Asia Pacific , Rajen Manicka , Joerg Schnackenberg , George Thouas , Max Biocare , Ewa Hudson , Ram Vishwakarma , Amanda Rao , Clinical Trials Emerging Research , Gut Microbiota Research , Department Of Medicine Therapeutics , Chinese University Of Hong Kong , Mcpherson Health , Council Of Scientific Industrial Research , Gn Corporation Japan , Health Science Department , Business Development ,

NutraIngredients Immunity Series: Join us live TODAY for opening broadcast on clinical trials and emerging research

NutraIngredients' interactive and FREE broadcast series focusing on immunity begins tomorrow, with the first APAC edition on clinical trials and emerging research coming live from our Singapore regional HQ. ....

United States , Sarah Culverhouse , Samuel Jk Abraham , Rebecca Edwards , Holista Colltech , Bevan Hayes , Gary Scattergood , Daisuke Fujiwara , Ankur Bhamu , Asia Pacific , Rajen Manicka , Joerg Schnackenberg , George Thouas , Max Biocare , Ewa Hudson , Ram Vishwakarma , Amanda Rao , Clinical Trials Emerging Research , Gut Microbiota Research , Department Of Medicine Therapeutics , Chinese University Of Hong Kong , Mcpherson Health , Council Of Scientific Industrial Research , Gn Corporation Japan , Health Science Department , Business Development ,

On a roll: Holista eyes APAC markets for low-GI bread premix after successful US Costanzo's partnership

Malaysia-based and Australia-listed food tech firm Holista Colltech has set its sights on marketing its low-GI bread premix in several APAC markets after a successful partnership in the United States with bakery manufacturer Costanzo’s.
Despite being based in APAC, Holista opted to start commercialisation with a partner in the United States as it wanted to reach a ‘major bread-eating’ market first, but now has its eye on markets closer to home as well.
“We preferred to launch in the United States as it is a major bread-eating country, and we also partnered well with Costanzo’s to put potential supply chain issues to rest early on in addition to observing a demand for such healthier options in the local market especially post-COVID-19,” Holista Colltech CEO Dr Rajen Manicka told ....

United States , Holista Colltech , Rajen Manicka , North America , ஒன்றுபட்டது மாநிலங்களில் , ராஜன் மாணிக்க , வடக்கு அமெரிக்கா ,